Cost of disorders of the brain in Europe 2010

Anders Gustavsson, Mikael Svensson, Frank Jacobi, +39

European Neuropsychopharmacology

NeuropsychologyPsychiatryEurope 2010NeuropsychiatryBrain Injury +6

Omega-3 fatty acids in major depressive disorder

Kuan‐Pin Su, Shih‐Yi Huang, Chih-Chiang Chiu, +1

European Neuropsychopharmacology

PsychiatryMood SymptomMedicineOmega-3 Fatty AcidDepression +2

Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism

Wayne C. Drevets

European Neuropsychopharmacology

Functional Anatomical CorrelatesPsychiatryPet MeasuresNeuroanatomyRegional Glucose Metabolism +10

Stress resilience during the coronavirus pandemic

Christiaan H. Vinkers, Thérèse van Amelsvoort, Jonathan I. Bisson, +9

European Neuropsychopharmacology

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

Franz X. Vollenweider, Klaus L. Leenders, I. Øye, +2

European Neuropsychopharmacology

Positron Emission TomographyCerebral Glucose UtilisationPsychiatryNeurophysiologyNeurophysiological Biomarkers +9

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence

Antoni Gual, Yuan He, Lars Torup, +2

European Neuropsychopharmacology

Substance AbuseAlcohol MisuseSubstance UsePsychiatryAlcohol Dependence +11

Development and validation of a social functioning scale, the Social Adaptation Self-evaluation Scale

M. Bosc, A. Dubini, V. Polin

European Neuropsychopharmacology

Behavioral SciencesSocial SkillsSocial Functioning ScaleSocial Skill AssessmentSocial Psychology +9

Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables

Stine Johnsen, Susanne Dam Nielsen, Keerthana Kunalan, +3

European Neuropsychopharmacology

Prevalence and burden of bipolar disorders in European countries

Stefano Pini, Valéria de Queiroz, Daniel Pagnin, +4

European Neuropsychopharmacology

PsychiatryMood SymptomGlobal HealthDepressionMood Spectrum +6

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

Anna Rickli, Olivier D. Moning, Marius C. Hoener, +1

European Neuropsychopharmacology

Psychoactive DrugMedicinePsychopharmacologyReceptor Interaction ProfilesNovel Psychoactive Tryptamines +6